Global Polyvalent Streptococcus Pneumococcal Vaccines Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
The polyvalent streptococcus pneumoniae vaccine is a vaccine that mainly prevents pneumonia caused by Streptococcus pneumoniae. It contains a variety of serotypes that often cause streptococcus pneumoniae infection. After vaccination, it can effectively reduce the risk of pneumonia infection.
LPI (LP Information)' newest research report, the “Polyvalent Streptococcus Pneumococcal Vaccines Industry Forecast” looks at past sales and reviews total world Polyvalent Streptococcus Pneumococcal Vaccines sales in 2022, providing a comprehensive analysis by region and market sector of projected Polyvalent Streptococcus Pneumococcal Vaccines sales for 2023 through 2029. With Polyvalent Streptococcus Pneumococcal Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Polyvalent Streptococcus Pneumococcal Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Polyvalent Streptococcus Pneumococcal Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Polyvalent Streptococcus Pneumococcal Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Polyvalent Streptococcus Pneumococcal Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Polyvalent Streptococcus Pneumococcal Vaccines and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Polyvalent Streptococcus Pneumococcal Vaccines.
The global Polyvalent Streptococcus Pneumococcal Vaccines market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Polyvalent Streptococcus Pneumococcal Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Polyvalent Streptococcus Pneumococcal Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Polyvalent Streptococcus Pneumococcal Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Polyvalent Streptococcus Pneumococcal Vaccines players cover GlaxoSmithKline, LG Chem, Merck, Panacea Biotec, AstraZeneca, Pfizer, Shire, Pnuvax Incorporated and Serum Institute, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Polyvalent Streptococcus Pneumococcal Vaccines market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Polyvalent Streptococcus Pneumococcal Vaccines market?
What factors are driving Polyvalent Streptococcus Pneumococcal Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Polyvalent Streptococcus Pneumococcal Vaccines market opportunities vary by end market size?
How does Polyvalent Streptococcus Pneumococcal Vaccines break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
The polyvalent streptococcus pneumoniae vaccine is a vaccine that mainly prevents pneumonia caused by Streptococcus pneumoniae. It contains a variety of serotypes that often cause streptococcus pneumoniae infection. After vaccination, it can effectively reduce the risk of pneumonia infection.
LPI (LP Information)' newest research report, the “Polyvalent Streptococcus Pneumococcal Vaccines Industry Forecast” looks at past sales and reviews total world Polyvalent Streptococcus Pneumococcal Vaccines sales in 2022, providing a comprehensive analysis by region and market sector of projected Polyvalent Streptococcus Pneumococcal Vaccines sales for 2023 through 2029. With Polyvalent Streptococcus Pneumococcal Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Polyvalent Streptococcus Pneumococcal Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Polyvalent Streptococcus Pneumococcal Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Polyvalent Streptococcus Pneumococcal Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Polyvalent Streptococcus Pneumococcal Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Polyvalent Streptococcus Pneumococcal Vaccines and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Polyvalent Streptococcus Pneumococcal Vaccines.
The global Polyvalent Streptococcus Pneumococcal Vaccines market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Polyvalent Streptococcus Pneumococcal Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Polyvalent Streptococcus Pneumococcal Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Polyvalent Streptococcus Pneumococcal Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Polyvalent Streptococcus Pneumococcal Vaccines players cover GlaxoSmithKline, LG Chem, Merck, Panacea Biotec, AstraZeneca, Pfizer, Shire, Pnuvax Incorporated and Serum Institute, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Polyvalent Streptococcus Pneumococcal Vaccines market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- 9-Valent
- 13-Valent
- 23-Valent
- Others
- Hospital
- Community Clinics
- Public Health Agencies
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GlaxoSmithKline
- LG Chem
- Merck
- Panacea Biotec
- AstraZeneca
- Pfizer
- Shire
- Pnuvax Incorporated
- Serum Institute
- Shinogi
- Shenzhen Kangtai Biological Products
- SK Bioscience
- Walvax Biotechnology
- Eli Lilly
- Abera
- Sanofi
- Genentech
What is the 10-year outlook for the global Polyvalent Streptococcus Pneumococcal Vaccines market?
What factors are driving Polyvalent Streptococcus Pneumococcal Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Polyvalent Streptococcus Pneumococcal Vaccines market opportunities vary by end market size?
How does Polyvalent Streptococcus Pneumococcal Vaccines break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Polyvalent Streptococcus Pneumococcal Vaccines by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Polyvalent Streptococcus Pneumococcal Vaccines by Country/Region, 2018, 2022 & 2029
2.2 Polyvalent Streptococcus Pneumococcal Vaccines Segment by Type
2.2.1 9-Valent
2.2.2 13-Valent
2.2.3 23-Valent
2.2.4 Others
2.3 Polyvalent Streptococcus Pneumococcal Vaccines Sales by Type
2.3.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Type (2018-2023)
2.3.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue and Market Share by Type (2018-2023)
2.3.3 Global Polyvalent Streptococcus Pneumococcal Vaccines Sale Price by Type (2018-2023)
2.4 Polyvalent Streptococcus Pneumococcal Vaccines Segment by Application
2.4.1 Hospital
2.4.2 Community Clinics
2.4.3 Public Health Agencies
2.4.4 Others
2.5 Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application
2.5.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Sale Market Share by Application (2018-2023)
2.5.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue and Market Share by Application (2018-2023)
2.5.3 Global Polyvalent Streptococcus Pneumococcal Vaccines Sale Price by Application (2018-2023)
3 GLOBAL POLYVALENT STREPTOCOCCUS PNEUMOCOCCAL VACCINES BY COMPANY
3.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Breakdown Data by Company
3.1.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Annual Sales by Company (2018-2023)
3.1.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Company (2018-2023)
3.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Annual Revenue by Company (2018-2023)
3.2.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Company (2018-2023)
3.2.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Company (2018-2023)
3.3 Global Polyvalent Streptococcus Pneumococcal Vaccines Sale Price by Company
3.4 Key Manufacturers Polyvalent Streptococcus Pneumococcal Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Polyvalent Streptococcus Pneumococcal Vaccines Product Location Distribution
3.4.2 Players Polyvalent Streptococcus Pneumococcal Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR POLYVALENT STREPTOCOCCUS PNEUMOCOCCAL VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Polyvalent Streptococcus Pneumococcal Vaccines Market Size by Geographic Region (2018-2023)
4.1.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Polyvalent Streptococcus Pneumococcal Vaccines Market Size by Country/Region (2018-2023)
4.2.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Annual Sales by Country/Region (2018-2023)
4.2.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Annual Revenue by Country/Region (2018-2023)
4.3 Americas Polyvalent Streptococcus Pneumococcal Vaccines Sales Growth
4.4 APAC Polyvalent Streptococcus Pneumococcal Vaccines Sales Growth
4.5 Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales Growth
4.6 Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales Growth
5 AMERICAS
5.1 Americas Polyvalent Streptococcus Pneumococcal Vaccines Sales by Country
5.1.1 Americas Polyvalent Streptococcus Pneumococcal Vaccines Sales by Country (2018-2023)
5.1.2 Americas Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Country (2018-2023)
5.2 Americas Polyvalent Streptococcus Pneumococcal Vaccines Sales by Type
5.3 Americas Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Polyvalent Streptococcus Pneumococcal Vaccines Sales by Region
6.1.1 APAC Polyvalent Streptococcus Pneumococcal Vaccines Sales by Region (2018-2023)
6.1.2 APAC Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Region (2018-2023)
6.2 APAC Polyvalent Streptococcus Pneumococcal Vaccines Sales by Type
6.3 APAC Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Polyvalent Streptococcus Pneumococcal Vaccines by Country
7.1.1 Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales by Country (2018-2023)
7.1.2 Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Country (2018-2023)
7.2 Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales by Type
7.3 Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines by Country
8.1.1 Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales by Country (2018-2023)
8.1.2 Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Country (2018-2023)
8.2 Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales by Type
8.3 Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Polyvalent Streptococcus Pneumococcal Vaccines
10.3 Manufacturing Process Analysis of Polyvalent Streptococcus Pneumococcal Vaccines
10.4 Industry Chain Structure of Polyvalent Streptococcus Pneumococcal Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Polyvalent Streptococcus Pneumococcal Vaccines Distributors
11.3 Polyvalent Streptococcus Pneumococcal Vaccines Customer
12 WORLD FORECAST REVIEW FOR POLYVALENT STREPTOCOCCUS PNEUMOCOCCAL VACCINES BY GEOGRAPHIC REGION
12.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Market Size Forecast by Region
12.1.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Forecast by Region (2024-2029)
12.1.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Polyvalent Streptococcus Pneumococcal Vaccines Forecast by Type
12.7 Global Polyvalent Streptococcus Pneumococcal Vaccines Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Information
13.1.2 GlaxoSmithKline Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
13.1.3 GlaxoSmithKline Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 GlaxoSmithKline Main Business Overview
13.1.5 GlaxoSmithKline Latest Developments
13.2 LG Chem
13.2.1 LG Chem Company Information
13.2.2 LG Chem Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
13.2.3 LG Chem Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 LG Chem Main Business Overview
13.2.5 LG Chem Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
13.3.3 Merck Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Panacea Biotec
13.4.1 Panacea Biotec Company Information
13.4.2 Panacea Biotec Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
13.4.3 Panacea Biotec Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Panacea Biotec Main Business Overview
13.4.5 Panacea Biotec Latest Developments
13.5 AstraZeneca
13.5.1 AstraZeneca Company Information
13.5.2 AstraZeneca Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
13.5.3 AstraZeneca Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 AstraZeneca Main Business Overview
13.5.5 AstraZeneca Latest Developments
13.6 Pfizer
13.6.1 Pfizer Company Information
13.6.2 Pfizer Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
13.6.3 Pfizer Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Pfizer Main Business Overview
13.6.5 Pfizer Latest Developments
13.7 Shire
13.7.1 Shire Company Information
13.7.2 Shire Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
13.7.3 Shire Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Shire Main Business Overview
13.7.5 Shire Latest Developments
13.8 Pnuvax Incorporated
13.8.1 Pnuvax Incorporated Company Information
13.8.2 Pnuvax Incorporated Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
13.8.3 Pnuvax Incorporated Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Pnuvax Incorporated Main Business Overview
13.8.5 Pnuvax Incorporated Latest Developments
13.9 Serum Institute
13.9.1 Serum Institute Company Information
13.9.2 Serum Institute Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
13.9.3 Serum Institute Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Serum Institute Main Business Overview
13.9.5 Serum Institute Latest Developments
13.10 Shinogi
13.10.1 Shinogi Company Information
13.10.2 Shinogi Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
13.10.3 Shinogi Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Shinogi Main Business Overview
13.10.5 Shinogi Latest Developments
13.11 Shenzhen Kangtai Biological Products
13.11.1 Shenzhen Kangtai Biological Products Company Information
13.11.2 Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
13.11.3 Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Shenzhen Kangtai Biological Products Main Business Overview
13.11.5 Shenzhen Kangtai Biological Products Latest Developments
13.12 SK Bioscience
13.12.1 SK Bioscience Company Information
13.12.2 SK Bioscience Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
13.12.3 SK Bioscience Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 SK Bioscience Main Business Overview
13.12.5 SK Bioscience Latest Developments
13.13 Walvax Biotechnology
13.13.1 Walvax Biotechnology Company Information
13.13.2 Walvax Biotechnology Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
13.13.3 Walvax Biotechnology Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Walvax Biotechnology Main Business Overview
13.13.5 Walvax Biotechnology Latest Developments
13.14 Eli Lilly
13.14.1 Eli Lilly Company Information
13.14.2 Eli Lilly Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
13.14.3 Eli Lilly Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Eli Lilly Main Business Overview
13.14.5 Eli Lilly Latest Developments
13.15 Abera
13.15.1 Abera Company Information
13.15.2 Abera Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
13.15.3 Abera Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Abera Main Business Overview
13.15.5 Abera Latest Developments
13.16 Sanofi
13.16.1 Sanofi Company Information
13.16.2 Sanofi Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
13.16.3 Sanofi Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Sanofi Main Business Overview
13.16.5 Sanofi Latest Developments
13.17 Genentech
13.17.1 Genentech Company Information
13.17.2 Genentech Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
13.17.3 Genentech Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Genentech Main Business Overview
13.17.5 Genentech Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Polyvalent Streptococcus Pneumococcal Vaccines by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Polyvalent Streptococcus Pneumococcal Vaccines by Country/Region, 2018, 2022 & 2029
2.2 Polyvalent Streptococcus Pneumococcal Vaccines Segment by Type
2.2.1 9-Valent
2.2.2 13-Valent
2.2.3 23-Valent
2.2.4 Others
2.3 Polyvalent Streptococcus Pneumococcal Vaccines Sales by Type
2.3.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Type (2018-2023)
2.3.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue and Market Share by Type (2018-2023)
2.3.3 Global Polyvalent Streptococcus Pneumococcal Vaccines Sale Price by Type (2018-2023)
2.4 Polyvalent Streptococcus Pneumococcal Vaccines Segment by Application
2.4.1 Hospital
2.4.2 Community Clinics
2.4.3 Public Health Agencies
2.4.4 Others
2.5 Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application
2.5.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Sale Market Share by Application (2018-2023)
2.5.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue and Market Share by Application (2018-2023)
2.5.3 Global Polyvalent Streptococcus Pneumococcal Vaccines Sale Price by Application (2018-2023)
3 GLOBAL POLYVALENT STREPTOCOCCUS PNEUMOCOCCAL VACCINES BY COMPANY
3.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Breakdown Data by Company
3.1.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Annual Sales by Company (2018-2023)
3.1.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Company (2018-2023)
3.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Annual Revenue by Company (2018-2023)
3.2.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Company (2018-2023)
3.2.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Company (2018-2023)
3.3 Global Polyvalent Streptococcus Pneumococcal Vaccines Sale Price by Company
3.4 Key Manufacturers Polyvalent Streptococcus Pneumococcal Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Polyvalent Streptococcus Pneumococcal Vaccines Product Location Distribution
3.4.2 Players Polyvalent Streptococcus Pneumococcal Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR POLYVALENT STREPTOCOCCUS PNEUMOCOCCAL VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Polyvalent Streptococcus Pneumococcal Vaccines Market Size by Geographic Region (2018-2023)
4.1.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Polyvalent Streptococcus Pneumococcal Vaccines Market Size by Country/Region (2018-2023)
4.2.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Annual Sales by Country/Region (2018-2023)
4.2.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Annual Revenue by Country/Region (2018-2023)
4.3 Americas Polyvalent Streptococcus Pneumococcal Vaccines Sales Growth
4.4 APAC Polyvalent Streptococcus Pneumococcal Vaccines Sales Growth
4.5 Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales Growth
4.6 Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales Growth
5 AMERICAS
5.1 Americas Polyvalent Streptococcus Pneumococcal Vaccines Sales by Country
5.1.1 Americas Polyvalent Streptococcus Pneumococcal Vaccines Sales by Country (2018-2023)
5.1.2 Americas Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Country (2018-2023)
5.2 Americas Polyvalent Streptococcus Pneumococcal Vaccines Sales by Type
5.3 Americas Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Polyvalent Streptococcus Pneumococcal Vaccines Sales by Region
6.1.1 APAC Polyvalent Streptococcus Pneumococcal Vaccines Sales by Region (2018-2023)
6.1.2 APAC Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Region (2018-2023)
6.2 APAC Polyvalent Streptococcus Pneumococcal Vaccines Sales by Type
6.3 APAC Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Polyvalent Streptococcus Pneumococcal Vaccines by Country
7.1.1 Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales by Country (2018-2023)
7.1.2 Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Country (2018-2023)
7.2 Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales by Type
7.3 Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines by Country
8.1.1 Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales by Country (2018-2023)
8.1.2 Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Country (2018-2023)
8.2 Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales by Type
8.3 Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Polyvalent Streptococcus Pneumococcal Vaccines
10.3 Manufacturing Process Analysis of Polyvalent Streptococcus Pneumococcal Vaccines
10.4 Industry Chain Structure of Polyvalent Streptococcus Pneumococcal Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Polyvalent Streptococcus Pneumococcal Vaccines Distributors
11.3 Polyvalent Streptococcus Pneumococcal Vaccines Customer
12 WORLD FORECAST REVIEW FOR POLYVALENT STREPTOCOCCUS PNEUMOCOCCAL VACCINES BY GEOGRAPHIC REGION
12.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Market Size Forecast by Region
12.1.1 Global Polyvalent Streptococcus Pneumococcal Vaccines Forecast by Region (2024-2029)
12.1.2 Global Polyvalent Streptococcus Pneumococcal Vaccines Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Polyvalent Streptococcus Pneumococcal Vaccines Forecast by Type
12.7 Global Polyvalent Streptococcus Pneumococcal Vaccines Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 GlaxoSmithKline
13.1.1 GlaxoSmithKline Company Information
13.1.2 GlaxoSmithKline Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
13.1.3 GlaxoSmithKline Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 GlaxoSmithKline Main Business Overview
13.1.5 GlaxoSmithKline Latest Developments
13.2 LG Chem
13.2.1 LG Chem Company Information
13.2.2 LG Chem Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
13.2.3 LG Chem Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 LG Chem Main Business Overview
13.2.5 LG Chem Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
13.3.3 Merck Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Panacea Biotec
13.4.1 Panacea Biotec Company Information
13.4.2 Panacea Biotec Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
13.4.3 Panacea Biotec Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Panacea Biotec Main Business Overview
13.4.5 Panacea Biotec Latest Developments
13.5 AstraZeneca
13.5.1 AstraZeneca Company Information
13.5.2 AstraZeneca Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
13.5.3 AstraZeneca Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 AstraZeneca Main Business Overview
13.5.5 AstraZeneca Latest Developments
13.6 Pfizer
13.6.1 Pfizer Company Information
13.6.2 Pfizer Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
13.6.3 Pfizer Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Pfizer Main Business Overview
13.6.5 Pfizer Latest Developments
13.7 Shire
13.7.1 Shire Company Information
13.7.2 Shire Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
13.7.3 Shire Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Shire Main Business Overview
13.7.5 Shire Latest Developments
13.8 Pnuvax Incorporated
13.8.1 Pnuvax Incorporated Company Information
13.8.2 Pnuvax Incorporated Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
13.8.3 Pnuvax Incorporated Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Pnuvax Incorporated Main Business Overview
13.8.5 Pnuvax Incorporated Latest Developments
13.9 Serum Institute
13.9.1 Serum Institute Company Information
13.9.2 Serum Institute Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
13.9.3 Serum Institute Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Serum Institute Main Business Overview
13.9.5 Serum Institute Latest Developments
13.10 Shinogi
13.10.1 Shinogi Company Information
13.10.2 Shinogi Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
13.10.3 Shinogi Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Shinogi Main Business Overview
13.10.5 Shinogi Latest Developments
13.11 Shenzhen Kangtai Biological Products
13.11.1 Shenzhen Kangtai Biological Products Company Information
13.11.2 Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
13.11.3 Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Shenzhen Kangtai Biological Products Main Business Overview
13.11.5 Shenzhen Kangtai Biological Products Latest Developments
13.12 SK Bioscience
13.12.1 SK Bioscience Company Information
13.12.2 SK Bioscience Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
13.12.3 SK Bioscience Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 SK Bioscience Main Business Overview
13.12.5 SK Bioscience Latest Developments
13.13 Walvax Biotechnology
13.13.1 Walvax Biotechnology Company Information
13.13.2 Walvax Biotechnology Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
13.13.3 Walvax Biotechnology Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Walvax Biotechnology Main Business Overview
13.13.5 Walvax Biotechnology Latest Developments
13.14 Eli Lilly
13.14.1 Eli Lilly Company Information
13.14.2 Eli Lilly Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
13.14.3 Eli Lilly Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Eli Lilly Main Business Overview
13.14.5 Eli Lilly Latest Developments
13.15 Abera
13.15.1 Abera Company Information
13.15.2 Abera Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
13.15.3 Abera Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Abera Main Business Overview
13.15.5 Abera Latest Developments
13.16 Sanofi
13.16.1 Sanofi Company Information
13.16.2 Sanofi Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
13.16.3 Sanofi Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Sanofi Main Business Overview
13.16.5 Sanofi Latest Developments
13.17 Genentech
13.17.1 Genentech Company Information
13.17.2 Genentech Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
13.17.3 Genentech Polyvalent Streptococcus Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Genentech Main Business Overview
13.17.5 Genentech Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Polyvalent Streptococcus Pneumococcal Vaccines Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Polyvalent Streptococcus Pneumococcal Vaccines Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 9-Valent
Table 4. Major Players of 13-Valent
Table 5. Major Players of 23-Valent
Table 6. Major Players of Others
Table 7. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales by Type (2018-2023) & (K Units)
Table 8. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Type (2018-2023)
Table 9. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Type (2018-2023) & ($ million)
Table 10. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Type (2018-2023)
Table 11. Global Polyvalent Streptococcus Pneumococcal Vaccines Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application (2018-2023) & (K Units)
Table 13. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Application (2018-2023)
Table 14. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Application (2018-2023)
Table 15. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Application (2018-2023)
Table 16. Global Polyvalent Streptococcus Pneumococcal Vaccines Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales by Company (2018-2023) & (K Units)
Table 18. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Company (2018-2023)
Table 19. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Company (2018-2023)
Table 21. Global Polyvalent Streptococcus Pneumococcal Vaccines Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Polyvalent Streptococcus Pneumococcal Vaccines Producing Area Distribution and Sales Area
Table 23. Players Polyvalent Streptococcus Pneumococcal Vaccines Products Offered
Table 24. Polyvalent Streptococcus Pneumococcal Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share Geographic Region (2018-2023)
Table 29. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Country/Region (2018-2023)
Table 33. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Polyvalent Streptococcus Pneumococcal Vaccines Sales by Country (2018-2023) & (K Units)
Table 36. Americas Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Country (2018-2023)
Table 37. Americas Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Country (2018-2023)
Table 39. Americas Polyvalent Streptococcus Pneumococcal Vaccines Sales by Type (2018-2023) & (K Units)
Table 40. Americas Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application (2018-2023) & (K Units)
Table 41. APAC Polyvalent Streptococcus Pneumococcal Vaccines Sales by Region (2018-2023) & (K Units)
Table 42. APAC Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Region (2018-2023)
Table 43. APAC Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Region (2018-2023)
Table 45. APAC Polyvalent Streptococcus Pneumococcal Vaccines Sales by Type (2018-2023) & (K Units)
Table 46. APAC Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application (2018-2023) & (K Units)
Table 47. Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales by Country (2018-2023) & (K Units)
Table 48. Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Country (2018-2023)
Table 49. Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Country (2018-2023)
Table 51. Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales by Type (2018-2023) & (K Units)
Table 52. Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Polyvalent Streptococcus Pneumococcal Vaccines
Table 60. Key Market Challenges & Risks of Polyvalent Streptococcus Pneumococcal Vaccines
Table 61. Key Industry Trends of Polyvalent Streptococcus Pneumococcal Vaccines
Table 62. Polyvalent Streptococcus Pneumococcal Vaccines Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Polyvalent Streptococcus Pneumococcal Vaccines Distributors List
Table 65. Polyvalent Streptococcus Pneumococcal Vaccines Customer List
Table 66. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Polyvalent Streptococcus Pneumococcal Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Polyvalent Streptococcus Pneumococcal Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Polyvalent Streptococcus Pneumococcal Vaccines Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Polyvalent Streptococcus Pneumococcal Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. GlaxoSmithKline Basic Information, Polyvalent Streptococcus Pneumococcal Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 81. GlaxoSmithKline Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
Table 82. GlaxoSmithKline Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. GlaxoSmithKline Main Business
Table 84. GlaxoSmithKline Latest Developments
Table 85. LG Chem Basic Information, Polyvalent Streptococcus Pneumococcal Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 86. LG Chem Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
Table 87. LG Chem Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. LG Chem Main Business
Table 89. LG Chem Latest Developments
Table 90. Merck Basic Information, Polyvalent Streptococcus Pneumococcal Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 91. Merck Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
Table 92. Merck Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Merck Main Business
Table 94. Merck Latest Developments
Table 95. Panacea Biotec Basic Information, Polyvalent Streptococcus Pneumococcal Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 96. Panacea Biotec Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
Table 97. Panacea Biotec Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Panacea Biotec Main Business
Table 99. Panacea Biotec Latest Developments
Table 100. AstraZeneca Basic Information, Polyvalent Streptococcus Pneumococcal Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 101. AstraZeneca Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
Table 102. AstraZeneca Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. AstraZeneca Main Business
Table 104. AstraZeneca Latest Developments
Table 105. Pfizer Basic Information, Polyvalent Streptococcus Pneumococcal Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 106. Pfizer Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
Table 107. Pfizer Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Pfizer Main Business
Table 109. Pfizer Latest Developments
Table 110. Shire Basic Information, Polyvalent Streptococcus Pneumococcal Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 111. Shire Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
Table 112. Shire Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Shire Main Business
Table 114. Shire Latest Developments
Table 115. Pnuvax Incorporated Basic Information, Polyvalent Streptococcus Pneumococcal Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 116. Pnuvax Incorporated Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
Table 117. Pnuvax Incorporated Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Pnuvax Incorporated Main Business
Table 119. Pnuvax Incorporated Latest Developments
Table 120. Serum Institute Basic Information, Polyvalent Streptococcus Pneumococcal Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 121. Serum Institute Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
Table 122. Serum Institute Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Serum Institute Main Business
Table 124. Serum Institute Latest Developments
Table 125. Shinogi Basic Information, Polyvalent Streptococcus Pneumococcal Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 126. Shinogi Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
Table 127. Shinogi Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Shinogi Main Business
Table 129. Shinogi Latest Developments
Table 130. Shenzhen Kangtai Biological Products Basic Information, Polyvalent Streptococcus Pneumococcal Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 131. Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
Table 132. Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Shenzhen Kangtai Biological Products Main Business
Table 134. Shenzhen Kangtai Biological Products Latest Developments
Table 135. SK Bioscience Basic Information, Polyvalent Streptococcus Pneumococcal Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 136. SK Bioscience Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
Table 137. SK Bioscience Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. SK Bioscience Main Business
Table 139. SK Bioscience Latest Developments
Table 140. Walvax Biotechnology Basic Information, Polyvalent Streptococcus Pneumococcal Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 141. Walvax Biotechnology Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
Table 142. Walvax Biotechnology Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Walvax Biotechnology Main Business
Table 144. Walvax Biotechnology Latest Developments
Table 145. Eli Lilly Basic Information, Polyvalent Streptococcus Pneumococcal Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 146. Eli Lilly Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
Table 147. Eli Lilly Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Eli Lilly Main Business
Table 149. Eli Lilly Latest Developments
Table 150. Abera Basic Information, Polyvalent Streptococcus Pneumococcal Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 151. Abera Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
Table 152. Abera Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 153. Abera Main Business
Table 154. Abera Latest Developments
Table 155. Sanofi Basic Information, Polyvalent Streptococcus Pneumococcal Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 156. Sanofi Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
Table 157. Sanofi Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 158. Sanofi Main Business
Table 159. Sanofi Latest Developments
Table 160. Genentech Basic Information, Polyvalent Streptococcus Pneumococcal Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 161. Genentech Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
Table 162. Genentech Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 163. Genentech Main Business
Table 164. Genentech Latest Developments
Table 1. Polyvalent Streptococcus Pneumococcal Vaccines Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Polyvalent Streptococcus Pneumococcal Vaccines Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 9-Valent
Table 4. Major Players of 13-Valent
Table 5. Major Players of 23-Valent
Table 6. Major Players of Others
Table 7. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales by Type (2018-2023) & (K Units)
Table 8. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Type (2018-2023)
Table 9. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Type (2018-2023) & ($ million)
Table 10. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Type (2018-2023)
Table 11. Global Polyvalent Streptococcus Pneumococcal Vaccines Sale Price by Type (2018-2023) & (US$/Unit)
Table 12. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application (2018-2023) & (K Units)
Table 13. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Application (2018-2023)
Table 14. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Application (2018-2023)
Table 15. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Application (2018-2023)
Table 16. Global Polyvalent Streptococcus Pneumococcal Vaccines Sale Price by Application (2018-2023) & (US$/Unit)
Table 17. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales by Company (2018-2023) & (K Units)
Table 18. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Company (2018-2023)
Table 19. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Company (2018-2023)
Table 21. Global Polyvalent Streptococcus Pneumococcal Vaccines Sale Price by Company (2018-2023) & (US$/Unit)
Table 22. Key Manufacturers Polyvalent Streptococcus Pneumococcal Vaccines Producing Area Distribution and Sales Area
Table 23. Players Polyvalent Streptococcus Pneumococcal Vaccines Products Offered
Table 24. Polyvalent Streptococcus Pneumococcal Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share Geographic Region (2018-2023)
Table 29. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Country/Region (2018-2023)
Table 33. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Polyvalent Streptococcus Pneumococcal Vaccines Sales by Country (2018-2023) & (K Units)
Table 36. Americas Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Country (2018-2023)
Table 37. Americas Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Country (2018-2023)
Table 39. Americas Polyvalent Streptococcus Pneumococcal Vaccines Sales by Type (2018-2023) & (K Units)
Table 40. Americas Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application (2018-2023) & (K Units)
Table 41. APAC Polyvalent Streptococcus Pneumococcal Vaccines Sales by Region (2018-2023) & (K Units)
Table 42. APAC Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Region (2018-2023)
Table 43. APAC Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Region (2018-2023)
Table 45. APAC Polyvalent Streptococcus Pneumococcal Vaccines Sales by Type (2018-2023) & (K Units)
Table 46. APAC Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application (2018-2023) & (K Units)
Table 47. Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales by Country (2018-2023) & (K Units)
Table 48. Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Country (2018-2023)
Table 49. Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Country (2018-2023)
Table 51. Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales by Type (2018-2023) & (K Units)
Table 52. Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Polyvalent Streptococcus Pneumococcal Vaccines
Table 60. Key Market Challenges & Risks of Polyvalent Streptococcus Pneumococcal Vaccines
Table 61. Key Industry Trends of Polyvalent Streptococcus Pneumococcal Vaccines
Table 62. Polyvalent Streptococcus Pneumococcal Vaccines Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Polyvalent Streptococcus Pneumococcal Vaccines Distributors List
Table 65. Polyvalent Streptococcus Pneumococcal Vaccines Customer List
Table 66. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Polyvalent Streptococcus Pneumococcal Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Polyvalent Streptococcus Pneumococcal Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Polyvalent Streptococcus Pneumococcal Vaccines Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Polyvalent Streptococcus Pneumococcal Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. GlaxoSmithKline Basic Information, Polyvalent Streptococcus Pneumococcal Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 81. GlaxoSmithKline Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
Table 82. GlaxoSmithKline Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. GlaxoSmithKline Main Business
Table 84. GlaxoSmithKline Latest Developments
Table 85. LG Chem Basic Information, Polyvalent Streptococcus Pneumococcal Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 86. LG Chem Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
Table 87. LG Chem Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. LG Chem Main Business
Table 89. LG Chem Latest Developments
Table 90. Merck Basic Information, Polyvalent Streptococcus Pneumococcal Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 91. Merck Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
Table 92. Merck Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Merck Main Business
Table 94. Merck Latest Developments
Table 95. Panacea Biotec Basic Information, Polyvalent Streptococcus Pneumococcal Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 96. Panacea Biotec Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
Table 97. Panacea Biotec Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Panacea Biotec Main Business
Table 99. Panacea Biotec Latest Developments
Table 100. AstraZeneca Basic Information, Polyvalent Streptococcus Pneumococcal Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 101. AstraZeneca Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
Table 102. AstraZeneca Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. AstraZeneca Main Business
Table 104. AstraZeneca Latest Developments
Table 105. Pfizer Basic Information, Polyvalent Streptococcus Pneumococcal Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 106. Pfizer Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
Table 107. Pfizer Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Pfizer Main Business
Table 109. Pfizer Latest Developments
Table 110. Shire Basic Information, Polyvalent Streptococcus Pneumococcal Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 111. Shire Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
Table 112. Shire Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Shire Main Business
Table 114. Shire Latest Developments
Table 115. Pnuvax Incorporated Basic Information, Polyvalent Streptococcus Pneumococcal Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 116. Pnuvax Incorporated Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
Table 117. Pnuvax Incorporated Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Pnuvax Incorporated Main Business
Table 119. Pnuvax Incorporated Latest Developments
Table 120. Serum Institute Basic Information, Polyvalent Streptococcus Pneumococcal Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 121. Serum Institute Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
Table 122. Serum Institute Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Serum Institute Main Business
Table 124. Serum Institute Latest Developments
Table 125. Shinogi Basic Information, Polyvalent Streptococcus Pneumococcal Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 126. Shinogi Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
Table 127. Shinogi Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Shinogi Main Business
Table 129. Shinogi Latest Developments
Table 130. Shenzhen Kangtai Biological Products Basic Information, Polyvalent Streptococcus Pneumococcal Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 131. Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
Table 132. Shenzhen Kangtai Biological Products Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Shenzhen Kangtai Biological Products Main Business
Table 134. Shenzhen Kangtai Biological Products Latest Developments
Table 135. SK Bioscience Basic Information, Polyvalent Streptococcus Pneumococcal Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 136. SK Bioscience Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
Table 137. SK Bioscience Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. SK Bioscience Main Business
Table 139. SK Bioscience Latest Developments
Table 140. Walvax Biotechnology Basic Information, Polyvalent Streptococcus Pneumococcal Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 141. Walvax Biotechnology Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
Table 142. Walvax Biotechnology Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Walvax Biotechnology Main Business
Table 144. Walvax Biotechnology Latest Developments
Table 145. Eli Lilly Basic Information, Polyvalent Streptococcus Pneumococcal Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 146. Eli Lilly Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
Table 147. Eli Lilly Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Eli Lilly Main Business
Table 149. Eli Lilly Latest Developments
Table 150. Abera Basic Information, Polyvalent Streptococcus Pneumococcal Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 151. Abera Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
Table 152. Abera Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 153. Abera Main Business
Table 154. Abera Latest Developments
Table 155. Sanofi Basic Information, Polyvalent Streptococcus Pneumococcal Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 156. Sanofi Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
Table 157. Sanofi Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 158. Sanofi Main Business
Table 159. Sanofi Latest Developments
Table 160. Genentech Basic Information, Polyvalent Streptococcus Pneumococcal Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 161. Genentech Polyvalent Streptococcus Pneumococcal Vaccines Product Portfolios and Specifications
Table 162. Genentech Polyvalent Streptococcus Pneumococcal Vaccines Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 163. Genentech Main Business
Table 164. Genentech Latest Developments
LIST OF FIGURES
Figure 1. Picture of Polyvalent Streptococcus Pneumococcal Vaccines
Figure 2. Polyvalent Streptococcus Pneumococcal Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Polyvalent Streptococcus Pneumococcal Vaccines Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 9-Valent
Figure 10. Product Picture of 13-Valent
Figure 11. Product Picture of 23-Valent
Figure 12. Product Picture of Others
Figure 13. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Type in 2022
Figure 14. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Type (2018-2023)
Figure 15. Polyvalent Streptococcus Pneumococcal Vaccines Consumed in Hospital
Figure 16. Global Polyvalent Streptococcus Pneumococcal Vaccines Market: Hospital (2018-2023) & (K Units)
Figure 17. Polyvalent Streptococcus Pneumococcal Vaccines Consumed in Community Clinics
Figure 18. Global Polyvalent Streptococcus Pneumococcal Vaccines Market: Community Clinics (2018-2023) & (K Units)
Figure 19. Polyvalent Streptococcus Pneumococcal Vaccines Consumed in Public Health Agencies
Figure 20. Global Polyvalent Streptococcus Pneumococcal Vaccines Market: Public Health Agencies (2018-2023) & (K Units)
Figure 21. Polyvalent Streptococcus Pneumococcal Vaccines Consumed in Others
Figure 22. Global Polyvalent Streptococcus Pneumococcal Vaccines Market: Others (2018-2023) & (K Units)
Figure 23. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Application (2022)
Figure 24. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Application in 2022
Figure 25. Polyvalent Streptococcus Pneumococcal Vaccines Sales Market by Company in 2022 (K Units)
Figure 26. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Company in 2022
Figure 27. Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market by Company in 2022 ($ Million)
Figure 28. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Company in 2022
Figure 29. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Geographic Region (2018-2023)
Figure 30. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Geographic Region in 2022
Figure 31. Americas Polyvalent Streptococcus Pneumococcal Vaccines Sales 2018-2023 (K Units)
Figure 32. Americas Polyvalent Streptococcus Pneumococcal Vaccines Revenue 2018-2023 ($ Millions)
Figure 33. APAC Polyvalent Streptococcus Pneumococcal Vaccines Sales 2018-2023 (K Units)
Figure 34. APAC Polyvalent Streptococcus Pneumococcal Vaccines Revenue 2018-2023 ($ Millions)
Figure 35. Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales 2018-2023 (K Units)
Figure 36. Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue 2018-2023 ($ Millions)
Figure 37. Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales 2018-2023 (K Units)
Figure 38. Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Revenue 2018-2023 ($ Millions)
Figure 39. Americas Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Country in 2022
Figure 40. Americas Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Country in 2022
Figure 41. Americas Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Type (2018-2023)
Figure 42. Americas Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Application (2018-2023)
Figure 43. United States Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 44. Canada Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 45. Mexico Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 46. Brazil Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 47. APAC Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Region in 2022
Figure 48. APAC Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Regions in 2022
Figure 49. APAC Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Type (2018-2023)
Figure 50. APAC Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Application (2018-2023)
Figure 51. China Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 52. Japan Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 53. South Korea Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 54. Southeast Asia Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 55. India Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 56. Australia Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 57. China Taiwan Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 58. Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Country in 2022
Figure 59. Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Country in 2022
Figure 60. Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Type (2018-2023)
Figure 61. Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Application (2018-2023)
Figure 62. Germany Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 63. France Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 64. UK Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 65. Italy Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 66. Russia Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 67. Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Country in 2022
Figure 68. Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Country in 2022
Figure 69. Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Type (2018-2023)
Figure 70. Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Application (2018-2023)
Figure 71. Egypt Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 72. South Africa Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 73. Israel Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 74. Turkey Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 75. GCC Country Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 76. Manufacturing Cost Structure Analysis of Polyvalent Streptococcus Pneumococcal Vaccines in 2022
Figure 77. Manufacturing Process Analysis of Polyvalent Streptococcus Pneumococcal Vaccines
Figure 78. Industry Chain Structure of Polyvalent Streptococcus Pneumococcal Vaccines
Figure 79. Channels of Distribution
Figure 80. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Forecast by Region (2024-2029)
Figure 81. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share Forecast by Region (2024-2029)
Figure 82. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share Forecast by Type (2024-2029)
Figure 83. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share Forecast by Type (2024-2029)
Figure 84. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share Forecast by Application (2024-2029)
Figure 85. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Polyvalent Streptococcus Pneumococcal Vaccines
Figure 2. Polyvalent Streptococcus Pneumococcal Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Polyvalent Streptococcus Pneumococcal Vaccines Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 9-Valent
Figure 10. Product Picture of 13-Valent
Figure 11. Product Picture of 23-Valent
Figure 12. Product Picture of Others
Figure 13. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Type in 2022
Figure 14. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Type (2018-2023)
Figure 15. Polyvalent Streptococcus Pneumococcal Vaccines Consumed in Hospital
Figure 16. Global Polyvalent Streptococcus Pneumococcal Vaccines Market: Hospital (2018-2023) & (K Units)
Figure 17. Polyvalent Streptococcus Pneumococcal Vaccines Consumed in Community Clinics
Figure 18. Global Polyvalent Streptococcus Pneumococcal Vaccines Market: Community Clinics (2018-2023) & (K Units)
Figure 19. Polyvalent Streptococcus Pneumococcal Vaccines Consumed in Public Health Agencies
Figure 20. Global Polyvalent Streptococcus Pneumococcal Vaccines Market: Public Health Agencies (2018-2023) & (K Units)
Figure 21. Polyvalent Streptococcus Pneumococcal Vaccines Consumed in Others
Figure 22. Global Polyvalent Streptococcus Pneumococcal Vaccines Market: Others (2018-2023) & (K Units)
Figure 23. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Application (2022)
Figure 24. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Application in 2022
Figure 25. Polyvalent Streptococcus Pneumococcal Vaccines Sales Market by Company in 2022 (K Units)
Figure 26. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Company in 2022
Figure 27. Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market by Company in 2022 ($ Million)
Figure 28. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Company in 2022
Figure 29. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Geographic Region (2018-2023)
Figure 30. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Geographic Region in 2022
Figure 31. Americas Polyvalent Streptococcus Pneumococcal Vaccines Sales 2018-2023 (K Units)
Figure 32. Americas Polyvalent Streptococcus Pneumococcal Vaccines Revenue 2018-2023 ($ Millions)
Figure 33. APAC Polyvalent Streptococcus Pneumococcal Vaccines Sales 2018-2023 (K Units)
Figure 34. APAC Polyvalent Streptococcus Pneumococcal Vaccines Revenue 2018-2023 ($ Millions)
Figure 35. Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales 2018-2023 (K Units)
Figure 36. Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue 2018-2023 ($ Millions)
Figure 37. Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales 2018-2023 (K Units)
Figure 38. Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Revenue 2018-2023 ($ Millions)
Figure 39. Americas Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Country in 2022
Figure 40. Americas Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Country in 2022
Figure 41. Americas Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Type (2018-2023)
Figure 42. Americas Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Application (2018-2023)
Figure 43. United States Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 44. Canada Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 45. Mexico Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 46. Brazil Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 47. APAC Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Region in 2022
Figure 48. APAC Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Regions in 2022
Figure 49. APAC Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Type (2018-2023)
Figure 50. APAC Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Application (2018-2023)
Figure 51. China Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 52. Japan Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 53. South Korea Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 54. Southeast Asia Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 55. India Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 56. Australia Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 57. China Taiwan Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 58. Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Country in 2022
Figure 59. Europe Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Country in 2022
Figure 60. Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Type (2018-2023)
Figure 61. Europe Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Application (2018-2023)
Figure 62. Germany Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 63. France Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 64. UK Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 65. Italy Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 66. Russia Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 67. Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Country in 2022
Figure 68. Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share by Country in 2022
Figure 69. Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Type (2018-2023)
Figure 70. Middle East & Africa Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share by Application (2018-2023)
Figure 71. Egypt Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 72. South Africa Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 73. Israel Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 74. Turkey Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 75. GCC Country Polyvalent Streptococcus Pneumococcal Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 76. Manufacturing Cost Structure Analysis of Polyvalent Streptococcus Pneumococcal Vaccines in 2022
Figure 77. Manufacturing Process Analysis of Polyvalent Streptococcus Pneumococcal Vaccines
Figure 78. Industry Chain Structure of Polyvalent Streptococcus Pneumococcal Vaccines
Figure 79. Channels of Distribution
Figure 80. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Forecast by Region (2024-2029)
Figure 81. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share Forecast by Region (2024-2029)
Figure 82. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share Forecast by Type (2024-2029)
Figure 83. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share Forecast by Type (2024-2029)
Figure 84. Global Polyvalent Streptococcus Pneumococcal Vaccines Sales Market Share Forecast by Application (2024-2029)
Figure 85. Global Polyvalent Streptococcus Pneumococcal Vaccines Revenue Market Share Forecast by Application (2024-2029)
